Sickle Cell Disease and Hematopoietic Cell Transplantation
This clinical resource explores HCT as a therapy for patients with sickle cell disease (SCD), by examining the following topics:
- Risk/benefit analysis for treatment decision-making
- Clinical trials, including Medicare coverage for HCT
- Research addressing quality of life issues
- HCT outcomes
- Trends in access to transplant for patients with SCD